| Company | Date | Position | Consensus ⓘ | Price Target ⓘ | 1-Yr Return | vs S&P 500 ⓘ |
|---|---|---|---|---|---|---|
|
MAZE
Maze Therapeutics, Inc.
|
Aug 12, 2026 | BUY |
Strong Buy
+129.8% avg upside
12 analysts
|
$48.00
76.29% Upside
|
+0.5% | · |
|
JBIO
Jade Biosciences
|
Aug 11, 2026 | BUY |
Strong Buy
+146.6% avg upside
16 analysts
|
$47.00
103.74% Upside
|
+2.6% | · |
|
VERA
Vera Therapeutics
|
Aug 11, 2026 | HOLD |
Strong Buy
+128.9% avg upside
19 analysts
|
$34.00
11.48% Upside
|
-3.7% | · |
|
SION
Sionna Therapeutics, Inc.
|
Aug 10, 2026 | HOLD |
Hold
+159.8% avg upside
12 analysts
|
$5.00
18.83% Downside
|
+45.3% | · |
|
BCRX
BioCryst
|
Aug 06, 2026 | BUY |
Strong Buy
+72.5% avg upside
24 analysts
|
$20.00
88.26% Upside
|
+0.9% | · |
|
VRDN
Viridian Therapeutics
|
Aug 06, 2026 | BUY |
Strong Buy
+53.0% avg upside
32 analysts
|
$41.00
77.15% Upside
|
-2.3% | · |
|
TVTX
Travere Therapeutics
|
Aug 06, 2026 | BUY |
Strong Buy
-8.9% avg upside
22 analysts
|
$75.00
21.61% Upside
|
-1.6% | · |
|
RARE
Ultragenyx Pharmaceutical
|
Aug 05, 2026 | HOLD |
Strong Buy
+147.8% avg upside
36 analysts
|
$30.00
12.30% Upside
|
+5.8% | · |
|
DNTH
Dianthus Therapeutics
|
Aug 05, 2026 | BUY |
Strong Buy
-11.9% avg upside
29 analysts
|
$122.00
10.67% Upside
|
-2.6% | · |
|
LRMR
Larimar Therapeutics
|
Aug 05, 2026 | BUY |
Strong Buy
+310.5% avg upside
22 analysts
|
$11.00
155.72% Upside
|
+5.1% | · |
|
NBIX
Neurocrine
|
Aug 03, 2026 | BUY |
Strong Buy
+19.2% avg upside
37 analysts
|
$194.00
22.82% Upside
|
-5.9% | · |
|
BIIB
Biogen
|
Jul 31, 2026 | HOLD |
Strong Buy
+21.4% avg upside
52 analysts
|
$215.00
4.14% Upside
|
+2.9% | · |
|
GOSS
Gossamer Bio
|
Jul 29, 2026 | HOLD |
Buy
+3714.3% avg upside
17 analysts
|
$1.00
455.58% Upside
|
-12.2% | · |
|
DNLI
Denali Therapeutics
|
Jul 13, 2026 | BUY |
Strong Buy
+52.6% avg upside
24 analysts
|
$26.00
3.07% Upside
|
-4.8% | · |
|
ARDX
Ardelyx
|
Jul 13, 2026 | BUY |
Strong Buy
+238.6% avg upside
21 analysts
|
$19.00
377.95% Upside
|
-22.4% | · |
|
CLYM
Climb Bio
|
Jul 10, 2026 | BUY |
Strong Buy
+33.3% avg upside
19 analysts
|
— | +4.3% | · |
|
EWTX
Edgewise Therapeutics
|
Jun 17, 2026 | BUY |
Strong Buy
+3.6% avg upside
15 analysts
|
$52.00
18.85% Upside
|
+24.0% | · |
|
PRAX
Praxis Precision Medicines
|
Jun 02, 2026 | SELL |
Strong Buy
+42.1% avg upside
24 analysts
|
$162.00
56.75% Downside
|
-42.8% | · |
|
SLDB
Solid Biosciences
|
May 18, 2026 | BUY |
Strong Buy
+75.2% avg upside
23 analysts
|
$16.00
75.34% Upside
|
+38.1% | · |
|
ANRO
Alto Neuroscience, Inc.
|
May 14, 2026 | HOLD |
Strong Buy
+4.2% avg upside
13 analysts
|
$24.00
18.37% Downside
|
+36.9% | · |
|
PEPG
PepGen Inc.
|
May 13, 2026 | BUY |
Strong Buy
+265.4% avg upside
9 analysts
|
$4.00
35.95% Upside
|
+57.3% | · |
|
OVID
Ovid Therapeutics
|
May 13, 2026 | BUY |
Strong Buy
+92.6% avg upside
18 analysts
|
$7.00
165.10% Upside
|
+0.0% | · |
|
PHVS
Pharvaris
|
May 13, 2026 | BUY |
Strong Buy
+29.0% avg upside
15 analysts
|
$42.00
20.42% Upside
|
+3.3% | · |
|
RGTI
Rigetti Computing
|
May 12, 2026 | BUY |
Strong Buy
+61.4% avg upside
14 analysts
|
$40.00
119.80% Upside
|
-1.1% | · |
|
STOK
Stoke Therapeutics
|
May 08, 2026 | BUY |
Strong Buy
+21.0% avg upside
18 analysts
|
$38.00
14.03% Upside
|
-1.0% | · |
|
XENE
Xenon
|
May 08, 2026 | BUY |
Strong Buy
-4.0% avg upside
28 analysts
|
$63.00
3.10% Downside
|
+13.8% | · |
|
VYGR
Voyager Therapeutics
|
Aug 07, 2024 | HOLD |
Strong Buy
+346.7% avg upside
23 analysts
|
$7.00
115.96% Upside
|
-54.3% | · |
|
RLYB
Rallybio
|
Apr 11, 2024 | BUY |
Buy
+41.2% avg upside
8 analysts
|
$11.00
33.56% Downside
|
-91.6% | · |
|
DSGN
Design Therapeutics
|
Mar 20, 2024 | HOLD |
Strong Buy
+25.1% avg upside
9 analysts
|
$5.00
65.68% Downside
|
+60.0% | · |
|
TSHA
Taysha Gene Therapies
|
Aug 12, 2022 | BUY |
Strong Buy
+116.5% avg upside
21 analysts
|
$5.00
20.58% Downside
|
-82.0% | · |
|
PASG
Passage Bio
|
Feb 11, 2022 | BUY |
Buy
+281.5% avg upside
14 analysts
|
$23.00
397.87% Upside
|
-67.6% | · |
|
TPST
Tempest Therapeutics
|
Aug 11, 2020 | HOLD |
Buy
+1711.4% avg upside
18 analysts
|
$45.00
3665.76% Upside
|
· | · |
|
BMRN
BioMarin Pharmaceutical
|
Jan 02, 2019 | HOLD |
Strong Buy
+35.2% avg upside
52 analysts
|
— | -1.1% | · |
|
VRTX
Vertex Pharmaceuticals
|
Jan 02, 2019 | HOLD |
Strong Buy
-15.5% avg upside
62 analysts
|
— | +33.8% | · |
|
IMUX
Immunic
|
Sep 12, 2018 | HOLD |
Strong Buy
+144.1% avg upside
21 analysts
|
— | -23.7% | · |
|
MTVA
MetaVia
|
Aug 13, 2018 | HOLD |
Strong Buy
+1934.1% avg upside
13 analysts
|
— | · | · |
|
REGN
Regeneron
|
Aug 08, 2018 | HOLD |
Strong Buy
-1.7% avg upside
58 analysts
|
— | -17.2% | · |
|
CRBP
Corbus Pharmaceuticals
|
Jan 18, 2018 | BUY |
Strong Buy
+270.1% avg upside
20 analysts
|
$24.00
152.63% Upside
|
· | · |
|
VIVS
VivoSim Labs
|
Jan 04, 2018 | HOLD |
Buy
+750.3% avg upside
5 analysts
|
— | · | · |
|
SGPYY
Sage Group
|
Dec 07, 2017 | BUY |
Buy
+45.1% avg upside
4 analysts
|
— | -25.7% | · |
|
TVRD
Tvardi Therapeutics
|
Jun 30, 2017 | BUY |
Buy
+922.5% avg upside
23 analysts
|
$30.00
1594.92% Upside
|
· | · |
Disclaimer: 13Foresight compiles analyst ratings and price targets from publicly available sources. Performance metrics, rankings and star ratings shown here are calculated independently by 13Foresight from historical market prices and may differ from figures published elsewhere. This information may be incomplete, delayed or inaccurate, is provided for research and informational purposes only, and is not investment advice. The underlying ratings and opinions are those of the respective analysts and their firms; 13Foresight accepts no liability for any decisions made based on this data.